This test is most useful if any of these apply to you.
If you have ever felt like your hunger runs hotter than your friends', or watched your weight creep up despite eating reasonably, part of the answer may be written in your DNA. This test reads a single letter in your genome that helps set how loudly your brain's appetite signals talk to you.
The variant itself will not predict your future, but it gives you a head start. Knowing you carry the higher-risk version is useful information when you are deciding how aggressively to manage weight, what kind of diet to prioritize, and how seriously to watch your blood sugar over the years.
MC4R (melanocortin-4 receptor) is a gene that codes for a receptor in your brain, mostly in the hypothalamus, that acts as a master switch for appetite and energy balance. The rs17782313 variant is a single letter change in the DNA near this gene, where the more common T is swapped for a C. The change does not alter the receptor protein itself; it sits about 188,000 letters away in an intergenic region.
The exact mechanism is still being worked out. Methylation studies suggest the C allele actually lowers methylation near MC4R and raises receptor mRNA, the opposite of a simple less-receptor story. Separate work points to changes in a nearby gene called DNAJC27 that appear to dampen MC4R signaling downstream, so the receptor may be made in normal or higher amounts while its message gets weaker. The net effect at the level you can feel is a louder hunger signal and a slightly higher set point for body weight.
Carrying one or two copies of the C version (the risk allele) is common. In population studies, the C allele shows up in roughly one in four to one in three people, depending on ancestry. Because it is so common, this is not a rare disease gene. It is a small dial that, when turned, modestly raises your set point for hunger and weight.
Across studies covering hundreds of thousands of people from Europe, East Asia, the Middle East, and South Asia, carrying the C allele is consistently linked to higher body weight. In one pooled analysis of 50 studies covering 58,716 people, C-allele carriers had a higher BMI (standardized mean difference 0.21 kg/m², 95% CI 0.12 to 0.29) and a larger waist (standardized mean difference 0.14 cm, 95% CI 0.06 to 0.23) than non-carriers. A long-term study in women found each C allele added about 0.2 kg/m² of extra BMI gain over a decade compared with non-carriers.
The size of the effect is small for any one person, but the direction is reliable. A large meta-analysis of 61 studies (about 80,957 people with obesity and 220,223 controls) found that each copy of the C allele raised the odds of being obese by about 18% (odds ratio 1.18, 95% CI 1.15 to 1.21). A newer meta-analysis of 39 studies reported that people with two copies of the C allele had roughly 73% higher odds of being overweight or obese than people with two copies of the T allele (odds ratio 1.73, 95% CI 1.51 to 1.98).
If you carry the C allele, your body is more likely to default toward higher hunger, more body fat, and more central weight. That is not a sentence; it is a tilt. Lifestyle and food environment still drive most of the variation in weight, but the dial in your brain may be set a notch louder than average.
A meta-analysis pooling studies on appetite found a clear link between the C allele and higher self-reported appetite, even though measured calorie intake did not consistently differ. In other words, carriers tend to feel hungrier, but whether that translates into eating more depends on the environment and behavior.
Beyond raw hunger, studies in 328 adults and 70 women with severe obesity linked the C allele to more emotional eating, food cravings, and a higher rate of severe binge eating. A separate analysis tied the C allele to food addiction symptoms and worse mental health in people with obesity. Carriers were also more likely to report depressed mood and overeating behaviors, especially when paired with an unhealthy diet pattern. Brain imaging work has found that these effects on eating behavior, along with greater gray matter volume in the amygdala, hippocampus, and orbitofrontal cortex, show up primarily in women, suggesting sex hormones interact with how the variant influences appetite circuits.
The C allele also raises diabetes risk, and not only because it raises weight. A meta-analysis of 123,373 people found each copy of the C allele increased odds of type 2 diabetes by about 10% (odds ratio 1.10, 95% CI 1.07 to 1.13). After adjusting for BMI, the link weakened but did not disappear (odds ratio 1.06, 95% CI 1.03 to 1.09), meaning some of the diabetes signal comes through paths beyond just adding pounds.
In a prospective study of 5,724 women in the Nurses' Health Study, each C allele was linked to about a 14% higher long-term diabetes risk after accounting for BMI and other factors. Fasting glucose tends to run slightly higher in C-allele carriers as well (standardized mean difference about 0.09 mg/dL, 95% CI 0.02 to 0.16).
Here the story gets interesting. Despite pushing weight and diabetes risk up, the variant does not appear to raise the odds of having a heart attack or stroke. The largest analysis, combining Danish cohorts, UK Biobank, and an elderly high-risk trial population (more than 460,000 people in total), found no link between rs17782313 and coronary artery disease (hazard ratio 1.03, 95% CI 0.99 to 1.07) or stroke (hazard ratio 0.93, 95% CI 0.85 to 1.01). In 1,439 patients undergoing carotid artery surgery, the variant also did not change plaque composition, with no differences in lipid content, macrophage infiltration, collagen, or calcification between carriers and non-carriers.
It might seem strange that a variant which raises weight and blood sugar does not raise cardiovascular events. The likely explanation is that rs17782313 is mainly an appetite and brain-side variant, not a vascular one. It pushes the inputs (hunger, weight, glucose) in the wrong direction, but it does not directly damage blood vessels. If you carry the C allele and your weight and blood sugar stay controlled, the downstream cardiovascular risk appears to behave like that of any other person with similar inputs. Knowing your genotype helps you focus on the levers that actually move heart risk: weight, lipids, blood pressure, and glucose.
The C allele is not equally bad in every environment. Multiple studies in overweight and obese adults show that the variant's effect on weight, waist size, and metabolic risk is amplified or buffered by what people eat and how they live.
On the protective side, adherence to a Nordic-style diet pattern (rich in fish, whole grains, berries, and vegetables) was linked to lower visceral fat in C-allele carriers. Taken together, these patterns suggest the variant amplifies the consequences of an unhealthy environment more than it dictates outcomes.
One question that comes up often: does the C allele blunt weight loss? The available data say no. In a study of 648 people followed for a year after bariatric surgery, MC4R common variants did not change weight loss outcomes. Lifestyle interventions in adults and adolescents also produced similar weight loss in carriers and non-carriers. The variant raises your baseline risk; it does not lock the door to losing weight.
Your genotype does not change. You only need to test rs17782313 once. The real value of the result is what you do with it, repeatedly, over years.
If you carry the C allele, the smart approach is to use that knowledge to track the markers that actually move: body weight, waist circumference, fasting glucose, HbA1c, fasting insulin, and a lipid panel. A reasonable cadence is a baseline now, repeat metabolic labs in three to six months if you are making lifestyle changes, then at least annually for life. Watching the trajectory matters more than any single number.
A positive result is not a diagnosis. It is a prompt to organize your monitoring and habits around the risks the variant nudges higher. Pair this test with metabolic labs that reveal early problems before symptoms appear, and consider involving a clinician trained in obesity medicine or endocrinology if your weight or blood sugar trend in the wrong direction.
Because this is a DNA test, the result is unusually stable. Your genotype will not change with fasting, illness, time of day, exercise, or medications. The most common sources of confusion are interpretation, not measurement:
MC4R Variant (rs17782313) is best interpreted alongside these tests.
MC4R Variant (rs17782313) is included in these pre-built panels.